Literature DB >> 23101692

A commentary on the safety of probiotics.

Fergus Shanahan1.   

Abstract

Probiotics have a long record of safety, which relates primarily to lactobacilli and bifidobacteria. Experience with other forms of probiotic is more limited. There is no such thing as zero risk, particularly in the context of certain forms of host susceptibility. There is poor public understanding of the concept of risk, in general, and risk/benefit analysis, in particular. Uncertainty persists regarding the potential for transfer of antibiotic resistance with probiotics, but the risk seems to be low with currently available probiotic products. As with other forms of therapeutics, the safety of probiotics should be considered on a strain-by-strain basis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Mesh:

Year:  2012        PMID: 23101692     DOI: 10.1016/j.gtc.2012.08.006

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  15 in total

Review 1.  Probiotics and necrotizing enterocolitis.

Authors:  Josef Neu
Journal:  Clin Perinatol       Date:  2014-09-30       Impact factor: 3.430

Review 2.  Minireview: Gut microbiota: the neglected endocrine organ.

Authors:  Gerard Clarke; Roman M Stilling; Paul J Kennedy; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  Mol Endocrinol       Date:  2014-06-03

Review 3.  Irritable bowel syndrome: a microbiome-gut-brain axis disorder?

Authors:  Paul J Kennedy; John F Cryan; Timothy G Dinan; Gerard Clarke
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 4.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

5.  Probiotics and prebiotics in infants and children.

Authors:  Y Vandenplas; E De Greef; T Devreker; G Veereman-Wauters; B Hauser
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

Review 6.  Probiotic use in horses - what is the evidence for their clinical efficacy?

Authors:  A Schoster; J S Weese; L Guardabassi
Journal:  J Vet Intern Med       Date:  2014-09-17       Impact factor: 3.333

Review 7.  Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer.

Authors:  Giuseppe L Banna; Francesco Torino; Francesco Marletta; Maria Santagati; Rossella Salemi; Elisa Cannarozzo; Luca Falzone; Francesco Ferraù; Massimo Libra
Journal:  Front Pharmacol       Date:  2017-09-01       Impact factor: 5.810

8.  Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial.

Authors:  Sanjay Patole; Anthony D Keil; Annie Chang; Elizabeth Nathan; Dorota Doherty; Karen Simmer; Meera Esvaran; Patricia Conway
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

Review 9.  Allergic diseases among children: nutritional prevention and intervention.

Authors:  Mohamed A Hendaus; Fatima A Jomha; Mohammad Ehlayel
Journal:  Ther Clin Risk Manag       Date:  2016-03-07       Impact factor: 2.423

10.  Whole-Genome Sequencing of Lactobacillus salivarius Strains BCRC 14759 and BCRC 12574.

Authors:  Shih-Hau Chiu; Chien-Chi Chen; Li-Ting Wang; Lina Huang
Journal:  Genome Announc       Date:  2017-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.